$HEB Recent News Ebola stocks: 2 to sell, and
Post# of 74540
Posted On: 10/20/2014 1:27:21 PM
$HEB Recent News
Ebola stocks: 2 to sell, and 5 to consider buying 12:09 p.m. Oct. 13, 2014 - The Trading Deck
Wednesday's biggest gaining and declining stocks 6:03 p.m. Dec. 2, 2009 - MarketWatch
Dyax, Santarus, CytRx soar; Hemispherx craters 12:38 p.m. Dec. 2, 2009 - Val Brickates Kennedy
Stocks in focus for Wednesday 7:47 p.m. Dec. 1, 2009 - MarketWatch
Ford tips higher, Santarus surges in late session 7:37 p.m. Dec. 1, 2009 - Laura Mandaro
Hemispherx Biopharma shares sink 44% after hours 6:29 p.m. Dec. 1, 2009 - Laura Mandaro
Oops: I have to eat crow over these stupid picks 9:55 a.m. June 19, 2009 - Chuck Jaffe
Vaccine makers get boost from flu scare 1:20 p.m. May 21, 2009 - Val Brickates Kennedy
Hemispherx leads drug stocks lower 1:29 p.m. May 19, 2009 - Val Brickates Kennedy
Dr. Reddy's, Hemispherx lead drug stocks 1:24 p.m. May 18, 2009 - Val Brickates Kennedy
Pigs will get slaughtered on swine-flu stocks 6:27 p.m. April 30, 2009 - Chuck Jaffe
Shares of antiviral drugmakers rocket on flu news 1:54 p.m. April 27, 2009 - Val Brickates Kennedy
Niche antiviral drugmakers rocket on flu news 10:08 a.m. April 27, 2009 - Val Brickates Kennedy
Hemispherx started at mkt outperform: Boenning & Scattergood 3:47 p.m. Dec. 4, 2006 - Tomi Kilgore
Tuesday's biggest stock gainers and decliners 6:21 p.m. Aug. 29, 2006 - Michael Baron
Short sellers dwindle as multiple forces aim to thwart strategy 11:51 a.m. June 14, 2006 - Alistair Barr
Highlights of rising and falling U.S. stocks 4:58 p.m. May 24, 2006 - MarketWatch
Bird-flu concerns knock airlines, Asian currencies 4:52 p.m. May 24, 2006 - Steve Goldstein
Drug stocks mixed, bird-flu drugmakers rally 4:51 p.m. May 24, 2006 - Val Brickates Kennedy
Hemisherx BioPharma up 10% at $2.95 9:39 a.m. May 24, 2006 - Tomi Kilgore
Hemispherx Announces Strategic Relationship With Squire Patton Boggs, Washington, DC As Governmental Counsel In Fight Against Ebola 11:01 a.m. Today - benzinga.com
Obama appoints Ebola czar 1:35 p.m. Oct. 17, 2014 - Seeking Alpha
Roller coaster ride continues for Ibio 9:09 a.m. Oct. 16, 2014 - Seeking Alpha
Second Texas Ebola case stokes the index 8:57 a.m. Oct. 15, 2014 - Seeking Alpha
Second healthcare worker contracts Ebola in U.S. 5:25 a.m. Oct. 15, 2014 - Seeking Alpha
Ibio jumps on possible ZMapp production ramp 4:18 p.m. Oct. 10, 2014 - Seeking Alpha
Alpha Pro Tech enjoying the Ebola ride 1:52 p.m. Oct. 9, 2014 - Seeking Alpha
Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear 1:38 p.m. Oct. 9, 2014 - Investors Business Daily
Ebola Outbreak Puts the Spotlight on 10 Biotech Companies 12:32 p.m. Oct. 8, 2014 - TheStreet.com
Ebola Patient Eric Duncan Dies; Related Stocks Fall On News 12:04 p.m. Oct. 8, 2014 - benzinga.com
Ebola Sector Shake Out Leaves Chimerix Inc On Top 1:08 p.m. Oct. 6, 2014 - benzinga.com
GeoVax jumps on the Ebola bandwagon 10:35 a.m. Oct. 2, 2014 - Seeking Alpha
Ebola-Related Pharma Stocks Soar On First U.S. Case 1:20 p.m. Oct. 1, 2014 - Investors Business Daily
Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks 10:08 a.m. Oct. 1, 2014 - TheStreet.com
FDA authorizes Tekmira to provide TKM-Ebola 11:20 a.m. Sept. 22, 2014 - Seeking Alpha
Ebola-Stricken Doc Receives Experimental Drug, But Which One? 2:20 p.m. Sept. 11, 2014 - TheStreet.com
Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity 9:36 a.m. Sept. 10, 2014 - TheStreet.com
WHO says Liberia may get overwhelmed by Ebola 7:20 a.m. Sept. 9, 2014 - Seeking Alpha
Hemispherx up in response to DoD Ebola collaboration 11:52 a.m. Sept. 8, 2014 - Seeking Alpha
10-Q: HEMISPHERX BIOPHARMA INC 4:08 p.m. Aug. 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Hemispherx Announces Strategic Relationship With Squire Patton Boggs, Washington, DC as Governmental Counsel in Fight Against Ebola 12:00 p.m. Today - GlobeNewswire
Hemispherx Biopharma Prevails in Multi-Million Dollar Federal Lawsuit 8:31 a.m. Today - GlobeNewswire
Hemispherx Biopharma Director Dr. William Mitchell to Present Research on Treating Deadly Emerging Viruses During the 4th World Congress on Virology October 8 8:31 a.m. Oct. 7, 2014 - GlobeNewswire
What's Next: Investors Place Ebola Pandemic Stock Bets 7:59 a.m. Oct. 6, 2014 - ACCESSWIRE
Hemispherx Biopharma Expands Research on Potential Ebola Treatments to Five Independent Experts/Institutional Collaborators 8:30 a.m. Sept. 29, 2014 - GlobeNewswire
Market Movers - Biotech Stocks - Hemispherx Biopharma, Aegerion Pharma, Cytori Therapeutics, Alnylam Pharma, and Rexahn Pharma 9:00 a.m. Sept. 25, 2014 - PR Newswire - PRF
Hemispherx Announces Primate Research Showing Alferon(R) LDO Protection From Pulmonary Damage Associated With Infection by Highly Pathogenic Influenza Virus 8:31 a.m. Sept. 22, 2014 - GlobeNewswire
Hemispherx' Drug Ampligen Plus Intranasal Seasonal Influenza Vaccine Induces Cross-Reactive Antibody Formation Against Avian H5N1 and H7N9 Influenza HA in Humans 8:31 a.m. Sept. 15, 2014 - GlobeNewswire
Hemispherx Biopharma and the Swiss Department of Defense, Civil Protection and Sports Expand Their Collaborative Research Agreement to Include the Study of Alferon(R) and Ampligen(R) Against the Ebola Virus 8:31 a.m. Sept. 10, 2014 - GlobeNewswire
Hemispherx Biopharma and United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Agree to Collaborate in Studying Alferon(R) and Ampligen(R) Against the Ebola Virus 8:31 a.m. Sept. 8, 2014 - GlobeNewswire
Hemispherx Biopharma to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th 8:30 a.m. Sept. 3, 2014 - GlobeNewswire
Market Movers - Biotech Stocks -- Progenics Pharma, Rexahn Pharma, ImmunoGen, Hemispherx Biopharma, and Incyte 9:20 a.m. Aug. 21, 2014 - PR Newswire - PRF
Hemispherx Biopharma Announces Financial Results for the Six Months Ended June 30, 2014 8:31 a.m. Aug. 11, 2014 - GlobeNewswire
Hemispherx's Two Drugs, Ampligen(R) and Alferon(R) Ranked Highly in Sensitivity Testing Against MERS/SARS Coronaviruses 8:30 a.m. Aug. 4, 2014 - GlobeNewswire
Hemispherx Achieves High Ranking in Sensitivity Testing Against MERS/SARS Coronaviruses Compared to Other Drugs 8:31 a.m. July 22, 2014 - GlobeNewswire
Hemispherx Biopharma and Bioclones Join Forces in Effort to Eradicate HIV/AIDS Virus Based on Recent Clinical Insights of Wistar Institute, University of Pennsylvania 8:31 a.m. July 8, 2014 - GlobeNewswire
Hemispherx Biopharma to Present During the 2014 BIO International Convention June 26 8:30 a.m. June 25, 2014 - GlobeNewswire
Hemispherx Announces New Publication With Potential Insight Into High Mortality Rate in Middle Eastern Respiratory Syndrome (MERS) 8:31 a.m. June 16, 2014 - GlobeNewswire
Hemispherx Announces That the University of Texas Medical Branch Confirms Activity of Alferon(R) N Against MERS (Middle East Respiratory Syndrome) Virus 1:08 p.m. June 3, 2014 - GlobeNewswire
Hemispherx Receives New U.S. Composition of Matter Patent Covering Ampligen(R) Formulations 9:28 a.m. May 27, 2014 - GlobeNewswire
Ebola stocks: 2 to sell, and 5 to consider buying 12:09 p.m. Oct. 13, 2014 - The Trading Deck
Wednesday's biggest gaining and declining stocks 6:03 p.m. Dec. 2, 2009 - MarketWatch
Dyax, Santarus, CytRx soar; Hemispherx craters 12:38 p.m. Dec. 2, 2009 - Val Brickates Kennedy
Stocks in focus for Wednesday 7:47 p.m. Dec. 1, 2009 - MarketWatch
Ford tips higher, Santarus surges in late session 7:37 p.m. Dec. 1, 2009 - Laura Mandaro
Hemispherx Biopharma shares sink 44% after hours 6:29 p.m. Dec. 1, 2009 - Laura Mandaro
Oops: I have to eat crow over these stupid picks 9:55 a.m. June 19, 2009 - Chuck Jaffe
Vaccine makers get boost from flu scare 1:20 p.m. May 21, 2009 - Val Brickates Kennedy
Hemispherx leads drug stocks lower 1:29 p.m. May 19, 2009 - Val Brickates Kennedy
Dr. Reddy's, Hemispherx lead drug stocks 1:24 p.m. May 18, 2009 - Val Brickates Kennedy
Pigs will get slaughtered on swine-flu stocks 6:27 p.m. April 30, 2009 - Chuck Jaffe
Shares of antiviral drugmakers rocket on flu news 1:54 p.m. April 27, 2009 - Val Brickates Kennedy
Niche antiviral drugmakers rocket on flu news 10:08 a.m. April 27, 2009 - Val Brickates Kennedy
Hemispherx started at mkt outperform: Boenning & Scattergood 3:47 p.m. Dec. 4, 2006 - Tomi Kilgore
Tuesday's biggest stock gainers and decliners 6:21 p.m. Aug. 29, 2006 - Michael Baron
Short sellers dwindle as multiple forces aim to thwart strategy 11:51 a.m. June 14, 2006 - Alistair Barr
Highlights of rising and falling U.S. stocks 4:58 p.m. May 24, 2006 - MarketWatch
Bird-flu concerns knock airlines, Asian currencies 4:52 p.m. May 24, 2006 - Steve Goldstein
Drug stocks mixed, bird-flu drugmakers rally 4:51 p.m. May 24, 2006 - Val Brickates Kennedy
Hemisherx BioPharma up 10% at $2.95 9:39 a.m. May 24, 2006 - Tomi Kilgore
Hemispherx Announces Strategic Relationship With Squire Patton Boggs, Washington, DC As Governmental Counsel In Fight Against Ebola 11:01 a.m. Today - benzinga.com
Obama appoints Ebola czar 1:35 p.m. Oct. 17, 2014 - Seeking Alpha
Roller coaster ride continues for Ibio 9:09 a.m. Oct. 16, 2014 - Seeking Alpha
Second Texas Ebola case stokes the index 8:57 a.m. Oct. 15, 2014 - Seeking Alpha
Second healthcare worker contracts Ebola in U.S. 5:25 a.m. Oct. 15, 2014 - Seeking Alpha
Ibio jumps on possible ZMapp production ramp 4:18 p.m. Oct. 10, 2014 - Seeking Alpha
Alpha Pro Tech enjoying the Ebola ride 1:52 p.m. Oct. 9, 2014 - Seeking Alpha
Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear 1:38 p.m. Oct. 9, 2014 - Investors Business Daily
Ebola Outbreak Puts the Spotlight on 10 Biotech Companies 12:32 p.m. Oct. 8, 2014 - TheStreet.com
Ebola Patient Eric Duncan Dies; Related Stocks Fall On News 12:04 p.m. Oct. 8, 2014 - benzinga.com
Ebola Sector Shake Out Leaves Chimerix Inc On Top 1:08 p.m. Oct. 6, 2014 - benzinga.com
GeoVax jumps on the Ebola bandwagon 10:35 a.m. Oct. 2, 2014 - Seeking Alpha
Ebola-Related Pharma Stocks Soar On First U.S. Case 1:20 p.m. Oct. 1, 2014 - Investors Business Daily
Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks 10:08 a.m. Oct. 1, 2014 - TheStreet.com
FDA authorizes Tekmira to provide TKM-Ebola 11:20 a.m. Sept. 22, 2014 - Seeking Alpha
Ebola-Stricken Doc Receives Experimental Drug, But Which One? 2:20 p.m. Sept. 11, 2014 - TheStreet.com
Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity 9:36 a.m. Sept. 10, 2014 - TheStreet.com
WHO says Liberia may get overwhelmed by Ebola 7:20 a.m. Sept. 9, 2014 - Seeking Alpha
Hemispherx up in response to DoD Ebola collaboration 11:52 a.m. Sept. 8, 2014 - Seeking Alpha
10-Q: HEMISPHERX BIOPHARMA INC 4:08 p.m. Aug. 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Hemispherx Announces Strategic Relationship With Squire Patton Boggs, Washington, DC as Governmental Counsel in Fight Against Ebola 12:00 p.m. Today - GlobeNewswire
Hemispherx Biopharma Prevails in Multi-Million Dollar Federal Lawsuit 8:31 a.m. Today - GlobeNewswire
Hemispherx Biopharma Director Dr. William Mitchell to Present Research on Treating Deadly Emerging Viruses During the 4th World Congress on Virology October 8 8:31 a.m. Oct. 7, 2014 - GlobeNewswire
What's Next: Investors Place Ebola Pandemic Stock Bets 7:59 a.m. Oct. 6, 2014 - ACCESSWIRE
Hemispherx Biopharma Expands Research on Potential Ebola Treatments to Five Independent Experts/Institutional Collaborators 8:30 a.m. Sept. 29, 2014 - GlobeNewswire
Market Movers - Biotech Stocks - Hemispherx Biopharma, Aegerion Pharma, Cytori Therapeutics, Alnylam Pharma, and Rexahn Pharma 9:00 a.m. Sept. 25, 2014 - PR Newswire - PRF
Hemispherx Announces Primate Research Showing Alferon(R) LDO Protection From Pulmonary Damage Associated With Infection by Highly Pathogenic Influenza Virus 8:31 a.m. Sept. 22, 2014 - GlobeNewswire
Hemispherx' Drug Ampligen Plus Intranasal Seasonal Influenza Vaccine Induces Cross-Reactive Antibody Formation Against Avian H5N1 and H7N9 Influenza HA in Humans 8:31 a.m. Sept. 15, 2014 - GlobeNewswire
Hemispherx Biopharma and the Swiss Department of Defense, Civil Protection and Sports Expand Their Collaborative Research Agreement to Include the Study of Alferon(R) and Ampligen(R) Against the Ebola Virus 8:31 a.m. Sept. 10, 2014 - GlobeNewswire
Hemispherx Biopharma and United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Agree to Collaborate in Studying Alferon(R) and Ampligen(R) Against the Ebola Virus 8:31 a.m. Sept. 8, 2014 - GlobeNewswire
Hemispherx Biopharma to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th 8:30 a.m. Sept. 3, 2014 - GlobeNewswire
Market Movers - Biotech Stocks -- Progenics Pharma, Rexahn Pharma, ImmunoGen, Hemispherx Biopharma, and Incyte 9:20 a.m. Aug. 21, 2014 - PR Newswire - PRF
Hemispherx Biopharma Announces Financial Results for the Six Months Ended June 30, 2014 8:31 a.m. Aug. 11, 2014 - GlobeNewswire
Hemispherx's Two Drugs, Ampligen(R) and Alferon(R) Ranked Highly in Sensitivity Testing Against MERS/SARS Coronaviruses 8:30 a.m. Aug. 4, 2014 - GlobeNewswire
Hemispherx Achieves High Ranking in Sensitivity Testing Against MERS/SARS Coronaviruses Compared to Other Drugs 8:31 a.m. July 22, 2014 - GlobeNewswire
Hemispherx Biopharma and Bioclones Join Forces in Effort to Eradicate HIV/AIDS Virus Based on Recent Clinical Insights of Wistar Institute, University of Pennsylvania 8:31 a.m. July 8, 2014 - GlobeNewswire
Hemispherx Biopharma to Present During the 2014 BIO International Convention June 26 8:30 a.m. June 25, 2014 - GlobeNewswire
Hemispherx Announces New Publication With Potential Insight Into High Mortality Rate in Middle Eastern Respiratory Syndrome (MERS) 8:31 a.m. June 16, 2014 - GlobeNewswire
Hemispherx Announces That the University of Texas Medical Branch Confirms Activity of Alferon(R) N Against MERS (Middle East Respiratory Syndrome) Virus 1:08 p.m. June 3, 2014 - GlobeNewswire
Hemispherx Receives New U.S. Composition of Matter Patent Covering Ampligen(R) Formulations 9:28 a.m. May 27, 2014 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼